Trade Summary

1 month ago, Fairmount Funds Management LLC, serving as Dir at Zenas Biopharma, Inc. (ZBIO), purchased 150,000 shares at $20.00 per share, for a total transaction value of $3,000,000.00. Following this transaction, Fairmount Funds Management LLC now holds 2,359,025 shares of ZBIO.

This purchase represents a 7.00% increase in Fairmount Funds Management LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 1, 2026, 1 day after the trade was made.

Zenas Biopharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.